Besides its ability to modulate MAPK signaling pathways, Spry1KO markedly induced cell cycle arrest and apoptosis, repressed cell proliferation in vitro, and impaired tumor growth in vivo, suggesting that Spry1 may display an oncogenic function in this tumor type. This evidence concerns the gene SPRY1 and neoplasm.